The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 07, 2020
Filed:
Jan. 08, 2015
Applicant:
1globe Biomedical Co., Ltd., Beijing, CN;
Inventors:
Chiang J. Li, Cambridge, MA (US);
Shyam Unniraman, Newton, MA (US);
Assignee:
1GLOBE BIOMEDICAL CO., LTD., Beijing, CN;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07H 21/04 (2006.01); C12N 15/00 (2006.01); C12N 15/63 (2006.01); C07K 14/735 (2006.01); C07K 14/725 (2006.01); C07K 14/705 (2006.01); A61K 35/17 (2015.01); C07K 14/715 (2006.01); A61K 48/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/70535 (2013.01); A61K 35/17 (2013.01); C07K 14/7051 (2013.01); C07K 14/70503 (2013.01); C07K 14/70521 (2013.01); C07K 14/70575 (2013.01); C07K 14/70578 (2013.01); C07K 14/7153 (2013.01); A61K 48/005 (2013.01); C07K 2319/03 (2013.01); C07K 2319/70 (2013.01);
Abstract
A novel synthetic biology-based ADCC technology is provided that enhances or enables ADCC response. The novel ADCC technology can be used to prevent or treat cancers, infectious, inflammatory or autoimmune diseases, and other diseases where elimination of diseased cells is desirable.
Li, Chiang. (2020). Synthetic biology-based adcc technology (U.S. Patent No. 10526392). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10526392
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile